Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of HUTCHMED (China) (NASDAQ:HCM) through any online brokerage.
Other companies in HUTCHMED (China)’s space includes: Supernus Pharmaceuticals Inc (NASDAQ:SUPN), WAVE Life Sciences Ltd (NASDAQ:WVE), Tarsus Pharmaceuticals Inc (NASDAQ:TARS), Phibro Animal Health Corp (NASDAQ:PAHC) and ANI Pharmaceuticals Inc (NASDAQ:ANIP).
HUTCHMED (China) has a consensus price target of $26.57.
The stock price for HUTCHMED (China) (NASDAQ: HCM) is $15.73 last updated January 16, 2026 at 7:07 AM EST.
There are no upcoming dividends for HUTCHMED (China).
HUTCHMED (China) does not have any upcoming earnings scheduled.
There is no upcoming split for HUTCHMED (China).
HUTCHMED (China) is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.